About the 3rd Annual RNAi-Based Therapeutics Summit
The 3rd Annual RNAi- Based Therapeutics Summit returns bigger and better than ever before to delve deep into the key remaining challenges associated with targeted delivery, CMC and clinical development of targeted siRNA therapeutics for modular, reproducible and effective gene silencing therapies against oncology, CNS, rare diseases and beyond.
Join the largest and fully dedicated platform for RNAi experts from large pharma, leading biotech and KOLs of academia to discuss the full and comprehensive range of RNAi drugs from discovery to development and beyond to stay ahead of the race in successfully developing targeted extrahepatic RNAi drugs that address unmet patient need.
Whether you are looking to improve your siRNA design, make your drugs targeted towards a specific tissue or advance your understanding of translation to clinical development hurdles associated with RNAi drugs, join thought leadership experts from the likes of Silence Therapeutics, AstraZeneca, Amgen and Sirnaomics in Boston for the most comprehensive and dedicated scientific and networking forum enabling you to seize the therapeutic opportunities of RNAi drugs.
Companies Attending
